ArticleCureus2026
Roth Spots As the Initial Manifestation of Accelerated-Phase Chronic Myeloid Leukemia.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Roth spots are white-centered retinal hemorrhages associated with various systemic conditions, particularly infective endocarditis and hematologic diseases. We report a case in which Roth spots were the presenting sign of accelerated-phase chronic myeloid leukemia. A 54-year-old man with no significant medical history presented to the ophthalmology emergency department with acute decreased vision in the left eye associated with fever and generalized weakness for four weeks. Fundus examination revealed multiple bilateral white-centered retinal hemorrhages consistent with Roth spots, associated with mild vitreous hemorrhage in the left eye. Laboratory investigations revealed severe anemia, marked leukocytosis, and thrombocytopenia. Peripheral blood smear and bone marrow examination confirmed the diagnosis of accelerated-phase chronic myeloid leukemia. The patient was referred to hematology and started on systemic treatment. This case highlights the importance of fundus examination in detecting systemic hematologic diseases and emphasizes that Roth spots may be the first manifestation of chronic myeloid leukemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.